BRPI1012077A2 - combinação de uma fonte de leucina e uma fonte de ácido graxo, e, composição nutricional, uma composição farmacêutica ou uma composição nutracêutica - Google Patents

combinação de uma fonte de leucina e uma fonte de ácido graxo, e, composição nutricional, uma composição farmacêutica ou uma composição nutracêutica

Info

Publication number: BRPI1012077A2
Authority: BR; Brazil
Prior art keywords: composition; source; combination; fatty acid; leucine
Prior art date: 2009-05-27

Application number

BRPI1012077A

Other languages

English (en)

Inventor

Lambertus Bertholdus Van Helvoort Adrianus

Faber Joyce

Van Norren Klaske

Johan Joseph Hageman Robert

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-27

Filing date

2010-05-27

Publication date

2018-03-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41397536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1012077(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-05-27 Application filed by Nutricia Nv filed Critical Nutricia Nv

2018-03-20 Publication of BRPI1012077A2 publication Critical patent/BRPI1012077A2/pt

2021-05-18 Publication of BRPI1012077B1 publication Critical patent/BRPI1012077B1/pt

2022-09-20 Publication of BRPI1012077B8 publication Critical patent/BRPI1012077B8/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Immunology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Toxicology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI1012077A 2009-05-27 2010-05-27 composição nutricional compreendendo uma combinação de uma fonte de leucina e uma fonte de ácido graxo poli-insaturado o-3, carboidratos digeríveis e fibra dietética solúvel BRPI1012077B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
NLPCT/NL2009/050297		2009-05-27
PCT/NL2009/050297 WO2010137944A1 (en)	2009-05-27	2009-05-27	Treatment of hypercalcaemia
PCT/NL2010/050319 WO2010137979A2 (en)	2009-05-27	2010-05-27	Hypercalcaemia

Publications (3)

Publication Number	Publication Date
BRPI1012077A2 true BRPI1012077A2 (pt)	2018-03-20
BRPI1012077B1 BRPI1012077B1 (pt)	2021-05-18
BRPI1012077B8 BRPI1012077B8 (pt)	2022-09-20

Family

ID=41397536

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1012077A BRPI1012077B8 (pt)	2009-05-27	2010-05-27	composição nutricional compreendendo uma combinação de uma fonte de leucina e uma fonte de ácido graxo poli-insaturado o-3, carboidratos digeríveis e fibra dietética solúvel

Country Status (12)

Country	Link
US (2)	US20120122785A1 (pt)
EP (2)	EP2435039B2 (pt)
CN (2)	CN104257646A (pt)
BR (1)	BRPI1012077B8 (pt)
DK (1)	DK2435039T4 (pt)
ES (1)	ES2555860T5 (pt)
HU (1)	HUE028295T2 (pt)
MX (1)	MX2011012573A (pt)
PL (1)	PL2435039T5 (pt)
PT (1)	PT2435039E (pt)
RU (1)	RU2555359C2 (pt)
WO (2)	WO2010137944A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TN2010000251A1 (fr) *	2010-06-03	2011-11-11	Rekik Raouf	N-acetyl-dl-leucine medicament neuro et retino protecteur
WO2012141575A1 (en)	2011-04-14	2012-10-18	N.V.Nutricia	Combination of epa, dpa and/or dha with a chemotherapeutic agent
JP2014512372A (ja) *	2011-04-18	2014-05-22	ネステクソシエテアノニム	α−ＨＩＣＡ及びエイコサペンタエン酸を含有する栄養組成物
WO2015002527A1 (en)	2013-07-05	2015-01-08	N.V. Nutricia	Amino acid composition for use in the treatment of a pdd
US9616292B2 (en) *	2015-01-09	2017-04-11	Nolan Orfield	Exercise tracker
US11197917B2 (en)	2017-12-01	2021-12-14	ByHeart, Inc.	Formulations for nutritional support in subjects in need thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05178758A (ja) *	1991-03-22	1993-07-20	Suntory Ltd	トリペプチドを有効成分とする骨疾患の予防および治療剤
EP0504938A3 (en) *	1991-03-22	1993-04-14	Suntory Limited	Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
JPH05140063A (ja)	1991-11-19	1993-06-08	Suntory Ltd	ジペプチド誘導体及びそれを有効成分とする骨疾患の予防及び治療剤
US6077828A (en) *	1996-04-25	2000-06-20	Abbott Laboratories	Method for the prevention and treatment of cachexia and anorexia
US20070037777A1 (en) *	2005-08-12	2007-02-15	Immunopath Profile, Inc.	Lipid-containing compositions and methods of using them
GB0003310D0 (en)	2000-02-15	2000-04-05	Univ Sheffield	Bone formation
NL1019368C2 (nl)	2001-11-14	2003-05-20	Nutricia Nv	Preparaat voor het verbeteren van receptorwerking.
US20040087490A1 (en) *	2002-09-20	2004-05-06	Troup John P.	Nutritional compositions
US20040171692A1 (en) *	2003-02-28	2004-09-02	Scutt Andrew	Modulation of bone formation
CA2516142A1 (en)	2003-03-18	2004-09-30	Novartis Ag	Compositions comprising fatty acids and amino acids
WO2004112507A1 (en) *	2003-06-23	2004-12-29	Nestec S.A.	Infant or follow-on formula
JP4702678B2 (ja) *	2004-06-07	2011-06-15	環境創研株式会社	競走馬用飼料添加材
US20060040001A1 (en) †	2004-07-28	2006-02-23	Johnson Catherine D	Nutritional compositions and methods for treating or preventing osteoporosis
ATE509624T1 (de)	2005-12-23	2011-06-15	Nutricia Nv	Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
GB0624879D0 (en) *	2006-12-14	2007-01-24	Shs Int Ltd	Treatment of pervasive development disorders
US20080171791A1 (en) *	2007-01-11	2008-07-17	Mdr Fitness Corp.	Compositions and Method for Losing Weight
US20080200425A1 (en) *	2007-02-16	2008-08-21	Kurtz Seymour J	Methods and compositions for regulating bone mineral density
WO2008147228A1 (en) *	2007-05-31	2008-12-04	Fonterra Corporate Research And Development Limited	Treatment or prevention of bone conditions
US7893067B2 (en) *	2007-06-27	2011-02-22	Medivir Ab	Cysteine protease inhibitors
EP2025248A1 (en) *	2007-07-31	2009-02-18	Fresenius Kabi Deutschland GmbH	Cachexia prevention supplement
WO2010002242A1 (en) *	2008-07-02	2010-01-07	N.V. Nutricia	Nutritional composition for improving muscle function and daily activity
CN101314031A (zh) *	2008-07-14	2008-12-03	王冰	一种改善骨营养的制剂

2009
- 2009-05-27 WO PCT/NL2009/050297 patent/WO2010137944A1/en not_active Ceased
2010
- 2010-05-27 BR BRPI1012077A patent/BRPI1012077B8/pt active IP Right Grant
- 2010-05-27 RU RU2011152873/15A patent/RU2555359C2/ru active
- 2010-05-27 DK DK10726616.5T patent/DK2435039T4/da active
- 2010-05-27 CN CN201410488463.7A patent/CN104257646A/zh active Pending
- 2010-05-27 HU HUE10726616A patent/HUE028295T2/en unknown
- 2010-05-27 PT PT107266165T patent/PT2435039E/pt unknown
- 2010-05-27 PL PL10726616T patent/PL2435039T5/pl unknown
- 2010-05-27 WO PCT/NL2010/050319 patent/WO2010137979A2/en not_active Ceased
- 2010-05-27 US US13/322,730 patent/US20120122785A1/en not_active Abandoned
- 2010-05-27 MX MX2011012573A patent/MX2011012573A/es not_active Application Discontinuation
- 2010-05-27 EP EP10726616.5A patent/EP2435039B2/en active Active
- 2010-05-27 CN CN201080033424.8A patent/CN102458390B/zh active Active
- 2010-05-27 ES ES10726616T patent/ES2555860T5/es active Active
- 2010-05-27 EP EP15184059.2A patent/EP2987485B1/en active Active
2014
- 2014-07-25 US US14/341,106 patent/US9867796B2/en active Active

Also Published As

Publication number	Publication date
EP2987485B1 (en)	2020-02-26
PL2435039T3 (pl)	2016-02-29
EP2435039A2 (en)	2012-04-04
RU2555359C2 (ru)	2015-07-10
BRPI1012077B1 (pt)	2021-05-18
EP2987485A1 (en)	2016-02-24
PT2435039E (pt)	2016-01-08
HUE028295T2 (en)	2016-12-28
ES2555860T5 (es)	2019-07-12
DK2435039T4 (da)	2019-05-06
ES2555860T3 (es)	2016-01-11
DK2435039T3 (en)	2015-12-21
WO2010137979A2 (en)	2010-12-02
EP2435039B1 (en)	2015-09-09
WO2010137979A8 (en)	2011-11-17
US20150018277A1 (en)	2015-01-15
US20120122785A1 (en)	2012-05-17
CN104257646A (zh)	2015-01-07
PL2435039T5 (pl)	2019-09-30
RU2011152873A (ru)	2013-07-10
BRPI1012077B8 (pt)	2022-09-20
EP2435039B2 (en)	2019-02-27
US9867796B2 (en)	2018-01-16
WO2010137979A3 (en)	2011-04-14
MX2011012573A (es)	2011-12-14
CN102458390B (zh)	2014-10-29
WO2010137944A1 (en)	2010-12-02
CN102458390A (zh)	2012-05-16

Legal Events

Date	Code	Title	Description
2018-04-10	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-23	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-10-01	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2020-10-06	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-12-15	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-04-27	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-05-18	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/05/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/05/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2022-09-13	B16B	Notification of grant cancelled [chapter 16.2 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 16.3 NA RPI NO 2629 DE 25/05/2021 POR TER SIDO INDEVIDA.
2022-09-20	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: RETIFICACAO REF. RPI 2628 DE 18/05/2021. PRAZO DE VALIDADE: 10 ANOS CONTADOS A PARTIR DE 18/05/2021, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME A ADI 5.529/DF, COM APOSTILAMENTO DO PRAZO DE VALIDADE DA PROTECAO DA MATERIA RELATIVA A PRODUTOS E PROCESSOS FARMACEUTICOS E EQUIPAMENTOS E/OU MATERIAIS DE USO EM SAUDE, PARA APLICACAO EM HUMANOS.

Publication	Publication Date	Title
EP2488146A4 (en)	2015-09-30	DRUGS LABELING
BRPI0915149A2 (pt)	2015-08-04	Composição nutricional, e usos de uma composição, e de um produto derivado de leite
PT2405942T (pt)	2018-02-07	Produto de administração oral
BR112012000421A2 (pt)	2019-09-24	composições e métodos para intensificar a produção de um produto biológico.
DK2252167T3 (da)	2013-06-17	Højprotein flydende enteral næringssammensætning
BR112012018842A2 (pt)	2015-09-01	Composição nutritiva enteral liquida e uso de uma composição líquida
BRPI1004940A2 (pt)	2018-06-19	composição farmacêutica
SG176688A1 (en)	2012-01-30	Semi-solid compositions and pharmaceutical products
BRPI1012539A2 (pt)	2016-03-29	composições farmacêuticas
PL2515941T3 (pl)	2020-04-30	Preparat farmaceutyczny zawierający bewacyzumab
LT3061445T (lt)	2023-09-25	Labai koncentruotos farmacinės kompozicijos
EP2448431A4 (en)	2014-12-31	BARRIER COMPOSITIONS AND OVEN-COOKED FOOD ENRICHED WITH OMEGA-3 FATTY ACID
BR112013016187A2 (pt)	2018-07-10	Produtos nutricionais compreendendo beta- hidróxi-beta metilbutirato de cálcio e ácido linoléico conjungado.
FR2948568B1 (fr)	2012-08-24	Formulation pharmaceutique
DK2508083T3 (da)	2019-05-20	Biologisk aktivt kosttilskud til profylakse af osteoporose sygdomme
PT3222272T (pt)	2022-01-27	Composição farmacêutica de carbetocina
EP2616053A4 (en)	2014-01-15	PHARMACEUTICAL COMPOSITIONS FROM CURCUMIN
ITTO20110641A1 (it)	2012-01-16	Composizioni farmaceutiche e metodi di trattamento
BRPI1014529A2 (pt)	2015-08-25	Composições de monoglicerídeo de ácido graxo
PL2557943T3 (pl)	2018-10-31	Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki
ZA201203767B (en)	2014-10-29	Branched-chain fatty acids and biological production thereof
BRPI1006953A2 (pt)	2016-04-26	composição farmacêutica, e, uso de uma composição
ZA201204619B (en)	2013-09-25	Pharmaceutical composition comprising vitamin d analogue and cosolventsurfactant mixture
BR112013027403A2 (pt)	2017-01-17	composições que compreendem uma antimetabólito de glicose e selênio
BR112012015082A2 (pt)	2017-03-07	compressor de uma hélice